3.8 Article

Outcomes of a mobile medical unit for low-threshold buprenorphine access targeting opioid overdose hot spots in Chicago

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Substance Abuse

Improving Research on Racial Disparities in Access to Medications to Treat Opioid Use Disorders

Tami L. Mark et al.

Summary: This study aims to review the association between access to medications for opioid use disorders (MOUD) and race, identify gaps in research methods, and propose new approaches to end racial disparities in access to MOUD. A literature review found that Black individuals had lower use of, or access to, MOUD compared to White individuals. To improve future research, clear conceptualization and interpretation of race, evaluation of intersectionality with other factors, measures of perceived racism and bias, collection of narratives, and evaluation of policy and programs are recommended.

JOURNAL OF ADDICTION MEDICINE (2023)

Article Emergency Medicine

An evaluation of the association between specific post-overdose care services in emergency departments and subsequent treatment engagement

Laura C. Chambers et al.

Summary: The objective of this study was to assess the association between specific post-overdose care services in the emergency department (ED) and subsequent engagement in treatment for opioid use disorder (OUD) after discharge. A retrospective cohort study was conducted on Rhode Island residents treated at 4 EDs for opioid overdose. The results showed that receipt of behavioral counseling in the ED and initiation of buprenorphine treatment in/from the ED were significantly associated with treatment engagement, while the provision of naloxone and referral to treatment at discharge were not associated with treatment engagement. Therefore, strategies for providing behavioral counseling and initiating buprenorphine treatment in the ED may improve OUD treatment after discharge.

JOURNAL OF THE AMERICAN COLLEGE OF EMERGENCY PHYSICIANS OPEN (2023)

Editorial Material Medicine, General & Internal

When Naloxone Isn't Enough

Sarah Messmer et al.

Summary: Not all drug users are interested in recovery support or medications for opioid use disorder, and the healthcare system does little to reduce the risk of death for patients who decline such care, despite available options.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Review Medicine, General & Internal

Mobile Narcotic Treatment Programs: On the Road Again?

Frank Breve et al.

Summary: Mobile narcotic treatment programs can provide treatment for opioid use disorder to more Americans, reduce the risk of HIV and hepatitis C, and reach marginalized populations. These programs have higher retention rates than fixed-site clinics and can benefit underserved communities, including the uninsured and homeless individuals. The use of technology can further enhance the support provided to mobile patients.

CUREUS JOURNAL OF MEDICAL SCIENCE (2022)

Review Psychiatry

The rise of illicit fentanyls, stimulants and the fourth wave of the opioid overdose crisis

Daniel Ciccarone

Summary: The review provides an update on the rising trend of illicit fentanyls, overdose risks, and treatment options, particularly focusing on the increasing use of synthetic opioids like fentanyl and its analogs in the US. Methamphetamine and cocaine-driven stimulant-related overdoses are also on the rise nationwide, contributing to the 'fourth wave' of high mortality involving these substances. The use of illicit fentanyls remains a major contributor to overdose deaths, and the increase in stimulant-related deaths seems to be connected to the ongoing opioid epidemic.

CURRENT OPINION IN PSYCHIATRY (2021)

Review Psychology, Clinical

Mobile methadone medication units: A brief history, scoping review and research opportunity

Brian Chan et al.

Summary: The history of mobile medication units in the US dates back to 1988, with recent attention and controversy surrounding their use. Research shows that mobile services can better assist underserved populations in accessing methadone and improving retention in care.

JOURNAL OF SUBSTANCE ABUSE TREATMENT (2021)

Editorial Material Substance Abuse

Defining Low-threshold Buprenorphine Treatment

Andrea Jakubowski et al.

JOURNAL OF ADDICTION MEDICINE (2020)

Article Public, Environmental & Occupational Health

Drug and Opioid-Involved Overdose Deaths - United States, 2017-2018

Nana Wilson et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2020)

Article Medicine, General & Internal

Comparative Effectiveness of Different Treatment Pathways for Opioid Use Disorder

Sarah E. Wakeman et al.

JAMA NETWORK OPEN (2020)

Review Clinical Neurology

Buprenorphine Treatment for Opioid Use Disorder: An Overview

Matisyahu Shulman et al.

CNS DRUGS (2019)

Article Substance Abuse

Co-occurring substance use and mental disorders among adults with opioid use disorder

Christopher M. Jones et al.

DRUG AND ALCOHOL DEPENDENCE (2019)

Letter Health Care Sciences & Services

Access to Treatment for Drug Use Disorders at US Health Centers: a National Study

Benjamin Bearnot et al.

JOURNAL OF GENERAL INTERNAL MEDICINE (2019)

Article Substance Abuse

Substance use and homelessness among emergency department patients

Kelly M. Doran et al.

DRUG AND ALCOHOL DEPENDENCE (2018)

Article Psychology, Clinical

Mobile opioid agonist treatment and public funding expands treatment for disenfranchised opioid-dependent individuals

Gerod Hall et al.

JOURNAL OF SUBSTANCE ABUSE TREATMENT (2014)

Review Medicine, General & Internal

Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence

R. P. Mattick et al.

COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2008)